Modular nucleic acid-based circuits for counters, binary operations, memory, and logic

US9624554B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9624554-B2
Application numberUS-201314135009-A
CountryUS
Kind codeB2
Filing dateDec 19, 2013
Priority dateDec 22, 2008
Publication dateApr 18, 2017
Grant dateApr 18, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

We have created novel engineered genetic counter designs and methods of use thereof that utilize DNA recombinases to provide modular systems, termed single invertase memory modules (SIMMs), for encoding memory in cells and cellular systems. Our designs are easily extended to compute to high numbers, by utilizing the >100 known recombinases to create subsequent modules. Flexibility in our engineered genetic counter designs is provided by daisy-chaining individual modular components, i.e., SIMMs together. These modular components of the engineered genetic counters can be combined in other network topologies to create circuits that perform, amongst other things, logic and memory. Our novel engineered genetic counter designs allow for the maintenance of memory and provide the ability to count between discrete states by expressing the recombinases between their cognate recognition sites.

First claim

Opening claim text (preview).

We claim: 1. A single invertase memory module (SIMM) engineered nucleic acid molecule comprising a nucleic acid sequence encoding: a forward recombinase recognition site (RRS for ), an inverted promoter sequence (iP inv ), a recombinase sequence (RC), a reverse recombinase recognition site (RRS rev ), [RRS for -iP inv -RC-RRS rev ],a ribosome binding site (RBS), a protein degradation tag sequence (D), and a transcriptional terminator sequence (T), where the recombinase encoded by the recombinase sequence is specific for the forward and reverse recombination recognition sites. 2. An inducer engineered genetic counter nucleic acid molecule comprising a nucleic acid sequence comprising an inducible promoter sequence (iP A ), at least one single invertase memory module (SIMM), and an output nucleic acid sequence encoding an output product (OP), where the SIMM comprises a forward recombinase recognition sequence (RRS for ), an inverted inducible promoter sequence (iP 1,inv ), a ribosome binding site (RBS), a recombinase gene sequence (RC), a degradation tag sequence (D), a transcriptional terminator sequence (T), and a reverse recombinase recognition sequence (RRS rev ), such that the inducer engineered genetic counter nucleic acid molecule comprises a nucleic acid molecule encoding the following components: iP A -[RRS 1,for -iP 1,inv -RBS-RC 1 -D-T-RRS 1,rev ] n -OP, wherein iP A and the iP 1 of each SIMM are responsive to the same inducer, wherein the recombinase encoded by each at least one SIMM is specific for the forward and reverse recombinase recognition site of that SIMM, and wherein n is an integer value≧1 and wherein the engineered genetic counter nucleic acid molecule is introduced into a cellular or non-cellular system. 3. The engineered genetic counter of claim 2 , wherein the recombinase sequence and the forward and reverse recombinase recognition sites of at least one SIMM comprise a Cre recombinase sequence of SEQ ID NO: 1002, and LoxP recombinase recognition sites comprising the sequence of SEQ ID NO:1 and SEQ ID NO:2. 4. The engineered genetic counter of claim 2 , wherein the recombinase sequence and the forward and reverse recombinase recognition sites of one SIMM comprise a Flp recombinase sequence of SEQ ID NO:3 or SEQ ID NO: 1002 and FRT recombinase recognition sites comprising the sequence of SEQ ID NO: 4. 5. The engineered genetic counter of claim 2 , wherein the recombinase sequence and the forward and reverse recombinase recognition sites of one SIMM comprise a Flp recombinase sequence of SEQ ID NO:3 or SEQ ID NO: 1002 and FRT recombinase recognition sites comprising the sequence of SEQ ID NO: 5. 6. The engineered genetic counter of claim 2 , wherein the recombinase sequence and the forward and reverse recombinase recognition sites of one SIMM comprise a FimB recombinase of SEQ ID NO: 9 and recombinase recognition sites comprising the sequence of SEQ ID NO: 7 and SEQ ID NO: 8. 7. The engineered genetic counter of claim 2 , wherein the recombinase sequence and the forward and reverse recombinase recognition sites of one SIMM comprise a FimE recombinase of SEQ ID NO: 10 and recombinase recognition sites comprising the sequence of SEQ ID NO: 7 and SEQ ID NO: 8 respectively. 8. The engineered genetic counter of claim 2 , wherein the recombinase sequence of one SIMM comprises a Cre recombinase of SEQ ID NO: 1002, and the LoxP recombinase recognition sites of that SIMM comprise a sequence selected from the group consisting of SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, and SEQ ID NO: 17. 9. The engineered genetic counter of claim 2 , wherein at least one inducible promoter comprises a sequence selected from the group consisting of a PLtet0-1 promoter of SEQ ID NO: 33, a PBAD promoter of SEQ ID NO: 34, a PTrc-2 promoter of SEQ ID NO: 35, a PLiaco-i promoter of SEQ ID NO: 36, a PAiLaco-i promoter of SEQ ID NO: 37, a Piac/ara-i promoter of SEQ ID NO: 38, and a PLSICOΠ promoter of SEQ ID NO: 39. 10. The engineered genetic counter of claim 2 , wherein at least one inducible promoter comprises a sequence selected from the group consisting of SEQ ID NO: 320-SEQ ID NO: 842. 11. The engineered genetic counter of claim 2 , wherein the RBS sequence of at least one SIMM comprises a sequence that is selected from the group consisting of SEQ ID NO: 843-SEQ ID NO: 850. 12. The engineered genetic counter of claim 2 , wherein the RBS sequence of at least one SIMM comprises a sequence that is selected from SEQ ID NO: 851-SEQ ID NO: 994. 13. The engineered genetic counter of claim 2 , wherein the protein degradation tag sequence of at least one SIMM comprises a sequence that is selected from the group consisting of sequences that encode for the peptides of SEQ ID NO: 995-SEQ ID NO: 1001. 14. A single-inducer engineered genetic counter nucleic acid molecule comprising a nucleic acid sequence encoding: an inducible promoter sequence (iP A ), one single invertase memory module (SIMM), and an output nucleic acid sequence encoding an output product (OP), where the SIMM comprises a forward recombinase recognition sequence (RRS for ), an inverted inducible promoter sequence (iP 1,inv ), a ribosome binding site (RBS), a recombinase gene sequence (RC), a degradation tag sequence (D), a transcriptional terminator sequence (T), and a reverse recombinase recognition sequence (RRS rev ), such that the single-inducer engineered genetic counter nucleic acid molecule comprises a nucleic acid sequence encoding the following components: iP A -[RRS 1,for -RBS-RC 1 -D-T-RRS 1,rev ]-OP, wherein iP A and iP 1 are responsive to the same inducer, and wherein the recombinase encoded by the SIMM is specific for the forward and reverse recombinase recognition site of the SIMM, and wherein the engineering genetic counter nucleic acid molecule is introduced into a cellular or non-cellular system. 15. The single-inducer engineered genetic counter of claim 14 , wherein the inducible promoter sequences iPA and iPi are responsive to arabinose. 16. The single-inducer engineered genetic counter of claim 14 , wherein the inducible promoter sequences iPA and iPi are PBAD promoter sequences. 17. The single-inducer engineered genetic counter of claim 14 , wherein the recombinase gene sequence (RCi) encodes an FIp recombinase and the forward (RRSfor) and reverse (RRSrev) recombinase recognition sites are FRTF and FRTR sites. 18. The single-inducer engineered genetic counter of claim 14 , wherein the output nucleic acid sequence encodes green fluorescent protein. 19. A single-inducer engineered genetic counter nucleic acid molecule comprising a nucleic acid sequence encoding: an inducible promoter sequence (iP A ), two single invertase memory modules (SIMMs), and an output nucleic acid sequence encoding an output product (OP), where each SIMM comprises a forward recombinase recognition sequence (RRS for ), an inverted inducible promoter sequence (iP inv ), a ribosome binding site (RBS), a recombinase gene sequence (RC), a degradation tag sequence (D), a transcriptional terminator sequence (T), and a reverse recombinase recognition sequence (RRS rev ), such that the single-inducer engineered genetic counter nucleic acid molecule comprising a nucleic acid sequence encoding the following components: iP A -[RRS 1,for -iP 1,inv -RBS-RC 1 -D-T-RRS 1,rev ]-[RRS 2,for -iP 1,inv -RBS-RC 2 -D-T-RRS 2,rev ]-OP, wherein iP A and iP 1 are responsive to the same inducer, and wherein the recombinase encoded by each SIMM is specific for the forward and reverse recombinase recognition site o

Assignees

Inventors

Classifications

  • C12Q1/6897Primary

    involving reporter genes operably linked to promoters · CPC title

  • Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline · CPC title

  • Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

  • DNA computing · CPC title

  • Recombinase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9624554B2 cover?
We have created novel engineered genetic counter designs and methods of use thereof that utilize DNA recombinases to provide modular systems, termed single invertase memory modules (SIMMs), for encoding memory in cells and cellular systems. Our designs are easily extended to compute to high numbers, by utilizing the >100 known recombinases to create subsequent modules. Flexibility in our engine…
Who is the assignee on this patent?
Collins James J, Lu Timothy Kuan-Ta, Univ Boston, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12Q1/6897. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).